Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The prognostic value and potential immunotherapeutic efficacy of ACVR1 in treating gastric cancer

1 Feb 2024

Abstract excerpt

Background: The discovery of biomarkers has facilitated the treatment of cancer. At present, the relationship between activin A receptor type-1 (ACVR1) and gastric cancer is gradually discovered. The aim of this study was to explore the expression of ACVR1 in gastric cancer and its clinical significance, to study the relationship between ACVR1 and tumor microenvironment (TME) for the prognosis of gastric cancer,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Ferroptosis and cancer prognosis
Share to TGF-β signaling in diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38482233
DOI: 10.21037/jgo-23-984

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The prognostic value and potential immunotherapeutic efficacy of ACVR1 in treating gastric cancerPMID 38482233Read ↗

Bioinformatics analysis of the prognosis and biological significance of VCAN in gastric cancerSemantic proximity Read ↗

Identification of VCAM1 as a Novel Biomarker in the Immune Microenvironment of Gastric Cancer by Comprehensive Bioinformatics AnalysisSemantic proximity Read ↗

ITGAV overexpression predicts poor prognosis in gastric cancerSemantic proximity Read ↗

Efficacy of immunotherapy in ARID1A-mutant solid tumors: a single-center retrospective studySemantic proximity Read ↗

ARID1A Mutations Are Associated with Increased Immune Activity in Gastrointestinal CancerSemantic proximity Read ↗

ITGB1 as a prognostic biomarker correlated with immune suppression in gastric cancerSemantic proximity Read ↗

The effects of ARID1A mutation in gastric cancer and its significance for treatmentSemantic proximity Read ↗

Somatic ARID1A mutation stratifies patients with gastric cancer to PD-1 blockade and adjuvant chemotherapy.Semantic proximity Read ↗

AFAP1L1 promotes gastric cancer progression by interacting with VAV2 to facilitate CDC42-mediated activation of ITGA5 signaling pathwaySemantic proximity Read ↗

Helicobacter pylori infection induces DNA double-strand breaks through the ACVR1/IRF3/POLD1 signaling axis to drive gastric tumorigenesisSemantic proximity Read ↗

CAV1 Impacts the Tumor Immune Microenvironment and Has Potential Value of Predicting Response to Immunotherapy in Esophageal CancerSemantic proximity Read ↗

AKR1B10 inhibits the proliferation and migration of gastric cancer via regulating epithelial-mesenchymal transitionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.